Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
about
Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@en
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@nl
type
label
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@en
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@nl
prefLabel
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@en
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@nl
P2093
P2860
P356
P1476
Dapagliflozin in patients with ...... ls in a phase IIa pilot study.
@en
P2093
Jeremy Pettus
Robert R Henry
Sunder Mudaliar
P2860
P304
P356
10.1111/DOM.12882
P577
2017-01-18T00:00:00Z